<DOC>
	<DOC>NCT01707368</DOC>
	<brief_summary>The purpose of this observational study is to document the course of disease and relapse management during treatment with Daivobet® Gel under consideration of patient`s individual application habits under daily use conditions.</brief_summary>
	<brief_title>Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<criteria>Patients with light to moderate psoriasis vulgaris of trunk and extremities and treatment with Daivobet® Gel was planned anyway. Minimum of 3 years diagnosed psoriasis vulgaris. Previous therapy with Daivobet® Gel Systemic therapy of psoriasis vulgaris Contraindications of Daivobet® Gel in the German package insert people that are incapable to give free consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Psoriasis vulgaris</keyword>
	<keyword>Plaque Psoriasis</keyword>
	<keyword>Daivobet® Gel</keyword>
	<keyword>Germany</keyword>
</DOC>